Eli Lilly Profile



Odds of Distress

Analyze Filter    Fiscal Quarter End: December 31, 2019
Equity ratings for Eli Lilly And Company are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 13, 2019 and ending today December 12, 2019. Click here to learn more.

Eli Lilly Profile

Next fiscal quarter end is expected on December 31, 2019. Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. Eli Lilly operates under Drug ManufacturersGeneral classification in USA and is traded on BATS Exchange. It employs 33910 people. more
Eli Lilly Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Eli Lilly And SEC Filings
Eli Lilly SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameEli Lilly And Company
PresidentJoshua SmileyView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Drug Manufacturers - General
InstrumentUSA Stock View All
RegionNorth America
LocationIndiana; U.S.A
Business AddressLilly Corporate Center
Foreign Associates
ExchangeBATS Exchange
CIK Number0000059478
Older SymbolLLY
IndustryDrug Manufacturers?General
Phone317 276 2000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestNovember 29, 2019
Eli Lilly And Company (LLY) is traded on BATS Exchange in USA. It is located in Lilly Corporate Center and employs 33,910 people. Eli Lilly And Company was previously known as ELI LILLY Co and was traded on BATS Exchange under the symbol LLY. Eli Lilly is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 104.71 B. Eli Lilly And runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 965.43 M outstanding shares of which 10.55 M shares are now shorted by investors with about 3.46 days to cover shorted positions. LILLY ELI CO has about 2.38 B in cash with 3.73 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.61.
Check Eli Lilly Probability Of Bankruptcy

Ownership Allocation (%)

Eli Lilly Target Price Odds Analysis

Odds Below 121.29HorizonTargetOdds Above 121.29
98.94%30 days 121.29 1.03%
Based on normal probability distribution, the odds of Eli Lilly to move above current price in 30 days from now is about 1.03 (This Eli Lilly And Company probability density function shows the probability of Eli Lilly Stock to fall within a particular range of prices over 30 days) .

Eli Lilly And Top Holders

Eli Lilly And Company Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Eli Lilly Key Fundamentals

Eli Lilly Against Markets

Did you try this?

Run Pattern Recognition Now


Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Eli Lilly Upcoming and Recent Events

Eli Lilly Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportJanuary 30, 2020
Next Earnings ReportMay 5, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndJanuary 30, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Eli Lilly Corporate Filings

Eli Lilly SEC Reporting

Financial Statements and Exhibits. Other Events
Submission of Matters to a Vote of Security Holders
Unclassified Corporate Event
Results of Operations and Financial Condition

Eli Lilly Distributions to stockholders

Eli Lilly Corporate Directors

Ellen Marram Lead Independent Director
Kathi Seifert Independent Director
Ralph Alvarez Independent Director
Please see also Stocks Correlation. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Search macroaxis.com